Croft-Leominster’s Encompass Health EHC Stock Holding History

Croft-Leominster’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-89,030	Closed	-$2.75M	–	141
2016 Q2	$2.75M	Buy	89,030 +2,967	+3%	+$92.8K	0.62%	58
2016 Q1	$2.58M	Buy	+86,063	New	+$2.38M	0.58%	58

Other funds holding EHC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Croft-Leominster's EHC Position: Q3 2016 in Review

Croft-Leominster sold out of Encompass Health (EHC) in Q3 2016, closing a stake of 89,030 shares — an estimated $2.75M sold.

Croft-Leominster first reported a position in EHC in Q1 2016 and held it in 2 quarters. The position peaked at $2.75M in Q2 2016. 271 funds tracked by Wall St. Rank hold EHC as of Q3 2016.

Croft-Leominster reported no remaining Encompass Health position as of Q3 2016 after selling out during the quarter.
Croft-Leominster sold 89,030 Encompass Health shares in Q3 2016, an estimated $2.75M.
Croft-Leominster first reported a position in Encompass Health in Q1 2016 and held it in 2 quarters.
Croft-Leominster's Encompass Health position peaked at $2.75M in Q2 2016.
271 funds tracked by Wall St. Rank held Encompass Health as of Q3 2016.

Based on Croft-Leominster's 13F filing for Q3 2016, filed 15 Nov 2016.